Susan Jenks

With many anti-cancer drugs taken orally, it's up to patients to comply with prescribed regimens — but what happens if they don't?

Biomarker research paves the way to precision cancer medicine.

People with cancer should ask questions about what biomarker tests are offered for their cancer type, what those tests offer and what they don't.

A new law hopes to speed drug development for therapies in the age of biomarker-driven treatment.

The cancer organization proposes new screening guidelines for lung cancer.